Transcription patterning of uncoupled proliferation and differentiation in myelodysplastic bone marrow with erythroid-focused arrays

被引:28
作者
Lee, YT
Miller, LD
Gubin, AN
Makhlouf, F
Wojda, U
Barrett, AJ
Liu, ET
Miller, JL
机构
[1] NIDDKD, Biol Chem Lab, NIH, Bethesda, MD 20892 USA
[2] NCI, Sect Mol Signalling & Oncogenesis, Div Clin Sci, NIH, Bethesda, MD 20892 USA
[3] NHLBI, Ctr Informat Technol, NIH, Bethesda, MD 20892 USA
[4] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1182/blood.V98.6.1914
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Because abnormal erythroid differentiation is the most common manifestation of the myelodysplastic syndromes (MDS), it was hypothesized that erythroid gene expression may be used to illustrate myelodysplastic transcription patterns. Ten normal bone marrow aspirates (NBM) were first analyzed using an erythroid-focused cDNA array to define steady-state transcription levels. Proliferation and differentiation gene subsets were identified by statistically significant differences between NBM and erythroleukemia gene expression. Next, cDNAs from 5 separate MDS aspirates were studied: refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (RAEB-T), and RAEB-T/secondary MDS. A distinct pattern of significantly increased proliferation-associated and reduced differentiation-associated gene activity was established for MDS.
引用
收藏
页码:1914 / 1921
页数:8
相关论文
共 26 条
[1]   P53 MUTATION IN THE MYELODYSPLASTIC SYNDROMES [J].
ADAMSON, DJA ;
DAWSON, AA ;
BENNETT, B ;
KING, DJ ;
HAITES, NE .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 89 (01) :61-66
[2]   Probing lymphocyte biology by genomic-scale gene expression analysis [J].
Alizadeh, A ;
Eisen, M ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
JOURNAL OF CLINICAL IMMUNOLOGY, 1998, 18 (06) :373-379
[3]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[4]   The relationship between the myelodysplastic syndromes and the myeloproliferative disorders [J].
Bain, BJ .
LEUKEMIA & LYMPHOMA, 1999, 34 (5-6) :443-+
[5]   CLONAL GROWTH OF HEMATOPOIETIC PROGENITOR CELLS FROM MYELODYSPLASTIC MARROW IN RESPONSE TO RECOMBINANT HEMOPOIETINS [J].
BAINES, P ;
BOWEN, D ;
JACOBS, A .
LEUKEMIA RESEARCH, 1990, 14 (03) :247-253
[6]  
Barrett J, 2000, SEMIN HEMATOL, V37, P15
[7]  
BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x
[8]   MOLECULAR THEMES IN ONCOGENESIS [J].
BISHOP, JM .
CELL, 1991, 64 (02) :235-248
[9]  
BOS JL, 1989, CANCER RES, V49, P4682
[10]   TELOMERASE ACTIVITY IN NORMAL LEUKOCYTES AND IN HEMATOLOGIC MALIGNANCIES [J].
COUNTER, CM ;
GUPTA, J ;
HARLEY, CB ;
LEBER, B ;
BACCHETTI, S .
BLOOD, 1995, 85 (09) :2315-2320